169 related articles for article (PubMed ID: 22944532)
1. 225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets.
Weidner JW; Mashnik SG; John KD; Ballard B; Birnbaum ER; Bitteker LJ; Couture A; Fassbender ME; Goff GS; Gritzo R; Hemez FM; Runde W; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2590-5. PubMed ID: 22944532
[TBL] [Abstract][Full Text] [Related]
2. Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.
Weidner JW; Mashnik SG; John KD; Hemez F; Ballard B; Bach H; Birnbaum ER; Bitteker LJ; Couture A; Dry D; Fassbender ME; Gulley MS; Jackman KR; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2602-7. PubMed ID: 22940414
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals.
Fitzsimmons J; Foley B; Torre B; Wilken M; Cutler CS; Mausner L; Medvedev D
Molecules; 2019 May; 24(10):. PubMed ID: 31109077
[TBL] [Abstract][Full Text] [Related]
4. Cyclotron production of Ac-225 for targeted alpha therapy.
Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
[TBL] [Abstract][Full Text] [Related]
5. Transport model predictions of
Burahmah N; Griswold JR; Heilbronn LH; Mirzadeh S
Appl Radiat Isot; 2021 Jun; 172():109676. PubMed ID: 33725503
[TBL] [Abstract][Full Text] [Related]
6. Defining Processing Times for Accelerator Produced
Fitzsimmons J; Griswold J; Medvedev D; Cutler CS; Mausner L
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897722
[TBL] [Abstract][Full Text] [Related]
7. Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
Melville G; Meriarty H; Metcalfe P; Knittel T; Allen BJ
Appl Radiat Isot; 2007 Sep; 65(9):1014-22. PubMed ID: 17532223
[TBL] [Abstract][Full Text] [Related]
8. Large scale accelerator production of
Griswold JR; Medvedev DG; Engle JW; Copping R; Fitzsimmons JM; Radchenko V; Cooley JC; Fassbender ME; Denton DL; Murphy KE; Owens AC; Birnbaum ER; John KD; Nortier FM; Stracener DW; Heilbronn LH; Mausner LF; Mirzadeh S
Appl Radiat Isot; 2016 Dec; 118():366-374. PubMed ID: 27776333
[TBL] [Abstract][Full Text] [Related]
9. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
[TBL] [Abstract][Full Text] [Related]
10. A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
Melville G; Fan Liu S; Allen BJ
Appl Radiat Isot; 2006 Sep; 64(9):979-88. PubMed ID: 16806950
[TBL] [Abstract][Full Text] [Related]
11. Chromatographic separation of the theranostic radionuclide
Mastren T; Radchenko V; Engle JW; Weidner JW; Owens A; Wyant LE; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
Anal Chim Acta; 2018 Jan; 998():75-82. PubMed ID: 29153089
[TBL] [Abstract][Full Text] [Related]
12. Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.
McAlister DR; Horwitz EP
Appl Radiat Isot; 2018 Oct; 140():18-23. PubMed ID: 29936271
[TBL] [Abstract][Full Text] [Related]
13. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
14. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
Perron R; Gendron D; Causey PW
Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
[TBL] [Abstract][Full Text] [Related]
15. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
16. Excitation functions for the production of 82Sr by proton bombardment of natRb at energies up to 100 MeV.
Buthelezi EZ; Nortier FM; Schroeder IW
Appl Radiat Isot; 2006 Aug; 64(8):915-24. PubMed ID: 16698273
[TBL] [Abstract][Full Text] [Related]
17. Reactor production of Thorium-229.
Hogle S; Boll RA; Murphy K; Denton D; Owens A; Haverlock TJ; Garland M; Mirzadeh S
Appl Radiat Isot; 2016 Aug; 114():19-27. PubMed ID: 27163437
[TBL] [Abstract][Full Text] [Related]
18. The application of poorly crystalline silicotitanate in production of
Fitzsimmons J; Abraham A; Catalano D; Younes A; Cutler CS; Medvedev D
Sci Rep; 2019 Aug; 9(1):11808. PubMed ID: 31413268
[TBL] [Abstract][Full Text] [Related]
19. Pairing of thorium with selected primary target materials in tandem configurations: Co-production of
Steyn GF; Motetshwane MA; Szelecsényi F; Brümmer JW
Appl Radiat Isot; 2021 Feb; 168():109514. PubMed ID: 33334657
[TBL] [Abstract][Full Text] [Related]
20. Production of 230U/226Th for targeted alpha therapy via proton irradiation of 231Pa.
Morgenstern A; Lebeda O; Stursa J; Bruchertseifer F; Capote R; McGinley J; Rasmussen G; Sin M; Zielinska B; Apostolidis C
Anal Chem; 2008 Nov; 80(22):8763-70. PubMed ID: 18925748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
